Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Tuspetinib Myeloid Kinase Inhibitor Safety and Efficacy As Monotherapy and Combined with Venetoclax in Phase 1/2 Trial of Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)

Naval Daver, Kyoo Hyung Lee, Yunsuk Choi, Brian A. Jonas, Martha Arellano, Paul B. Koller, Chul W. Jung, Sang Kyun Sohn, Amir T. Fathi, Jeong-Ok Lee, Sung-Soo Yoon, Justin M. Watts, Pankit Vachhani, Ho-Jin Shin, Jia Hu, Ranjeet Sinha, Nawazish Khan, William G. Rice, Rafael Bejar

Blood (2023) 142 (Supplement 1): 162.

https://doi.org/10.1182/blood-2023-182296

Published: 2023

Journal Articles

A Phase 1/2 Dose Escalation Study of the Myeloid Kinase Inhibitor HM43239 in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Naval Daver, Kyoo Hyung Lee, Brian A. Jonas, Martha L. Arellano, Chul W. Jung, Sang Kyun Sohn, Sung-Soo Yoon, Jeong-Ok Lee, Jia Hu, Ranjeet Kumar Sinha, William G Rice, Rafael Bejar

Blood (2022) 140 (Supplement 1): 6197–6199.

https://doi.org/10.1182/blood-2022-167972

Published: 2022

Journal Articles

Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease

Dong Won Baek, Sr., Joon Ho Moon, Jae-Sook Ahn, Seong Kyu Park, Ik Chan Song, Ho-Sup Lee, Won Sik Lee, Jong Ho Won, Hong Ghi Lee, June-Won Cheong, Yeung-Chul Mun, Chul W. Jung, Je-Hwan Lee, Hyeoung-Joon Kim, Sang Kyun Sohn

Blood (2021) 138 (Supplement 1): 2889.

https://doi.org/10.1182/blood-2021-154470

Published: 2021

Journal Articles

Long-Term Update from the Open-Label Extension of the NEURO-TTR Study in Patients with Hereditary Transthyretin Amyloidosis

Thomas Brannagan, Annabel K. Wang, Teresa Coelho, Marcia Waddington Cruz, Michael J. Polydefkis, Peter J. Dyck, Violaine Plante-Bordeneuve, John L. Berk, Fabio Barroso, Giampaolo Merlini, Isabel Conceição, Steven G. Hughes, Jesse G. Kwoh, Shiangtung W. Jung, Spencer Guthrie, Michael Pollock, Merrill D. Benson, Morie A. Gertz, MD

Blood (2018) 132 (Supplement 1): 498.

https://doi.org/10.1182/blood-2018-99-116995

Published: 2018

Journal Articles

Final Study Results of Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 48 Months Follow-up

Blood (2018) 132 (Supplement 1): 1733.

https://doi.org/10.1182/blood-2018-99-110568

Published: 2018

Journal Articles

Intravenous Iron Supplementation Alone for Treatment of Anemia in Cancer Patients

Silvia Park, Chul W. Jung, MD PhD, Jun Ho Jang, MD PhD

Blood (2017) 130 (Supplement 1): 4756.

https://doi.org/10.1182/blood.V130.Suppl_1.4756.4756

Published: 2017

Journal Articles

Deeper Molecular Response in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 36 Months Follow-up

Blood (2017) 130 (Supplement 1): 317.

https://doi.org/10.1182/blood.V130.Suppl_1.317.317

Published: 2017

Journal Articles

Overall Survival by Prognosis Score in High-Risk Myelodysplastic Syndromes (MDS) Patients Receiving Decitabine Treatment: Results From Clinical Experience

Marcelo Iastrebner, MD, Jun Ho Jang, MD, Kihyun Kim, MD, Chul W. Jung, MD, PhD, Elsa Nucifora, MD, Federico Sackmann, Sergio Orlando, MD, Graciela Klein, MD, Juan Garcia, MD, Carolina Belli, PhD, Luis Quiroga, MD, Fernando Santini, MD, Haydee i Bernard, MD, Lino Salvatierra, MD, Gustavo Taborda, MD, Raquel Bengió, MD

Blood (2011) 118 (21): 5024.

https://doi.org/10.1182/blood.V118.21.5024.5024

Published: 2011

Journal Articles

Bone Marrow Cellularity Is a Single Most Important Independent Prognostic Factor In AML Patients with t(8;21)

Blood (2010) 116 (21): 1707.

https://doi.org/10.1182/blood.V116.21.1707.1707

Published: 2010

Journal Articles

Clinical Characteristics of Thrombotic Thrombocytopenic Purpura with Severe ADAMTS13 Deficiency

Moon Jang, MD, PhD, So Young Chong, MD, PhD, Inho Kim, MD, PhD, Chul W. Jung, MD, PhD, Doyeun Oh, MD, PhD

Blood (2010) 116 (21): 4666.

https://doi.org/10.1182/blood.V116.21.4666.4666

Published: 2010

Journal Articles

Molecular Predictive Markers in Dose Escalation Treatment for Suboptimal Responders to Standard Dose Imatinib in CML

Blood (2008) 112 (11): 3221.

https://doi.org/10.1182/blood.V112.11.3221.3221

Published: 2008

Journal Articles

Prediction of Survival in Patients with Myelodysplastic Syndrome According to WHO Classification-Based Prognostic Scoring System (WPSS).

Jun Ho Jang, MD, Kihyun Kim, M.D., Chul W. Jung, M.D. Ph.D., Keon Woo Park, M.D.

Blood (2007) 110 (11): 4617.

https://doi.org/10.1182/blood.V110.11.4617.4617

Published: 2007

Journal Articles

Clinical Features and Treatment Outcomes of Primary Testicular Lymphoma.

Byeong-Bae Park, MD, Jong Gwang Kim, MD,PhD, HyeonSeok Eom, MD,PhD, Hyo Jin Kim, MD,PhD, Hyuck Chan Kwon, MD,PhD, Sung Yong Oh, MD, Jung Hun Kang, MD, Suk Joong Oh, MD,PhD, Ho-Jin Shin, MD,PhD, Cheolwon Suh, MD,PhD, Jung Han Kim, MD, Ho Young Kim, MD, Sang Cheol Lee, MD, Kihyun Kim, MD,PhD, Chul W. Jung, MD,PhD, Won Seog Kim, MD,PhD

Blood (2006) 108 (11): 4670.

https://doi.org/10.1182/blood.V108.11.4670.4670

Published: 2006

Journal Articles

Prospective Clinical Study of Surgical Resection Followed by CHOP in Localized Intestinal Lymphoma.

Jeeyun Lee, MD, Won Seog Kim, MD, Sung Yong Oh, MD, Jung Mi Kwon, MD, Hyun Jung Kim, MD, Hyo-Rak Lee, MD, Byeong Bae Park, MD, Kihyun Kim, MD, Chul W. Jung, MD, Keunchil Park, MD

Blood (2005) 106 (11): 4743.

https://doi.org/10.1182/blood.V106.11.4743.4743

Published: 2005

Journal Articles

A Randomized Trial of Heparin Plus Anti-Thrombin III (ATIII) vs. Heparin Alone To Prevent VOD after HSCT.

Chul W. Jung, MD, Jeeyun Lee, MD, Byeong Bae Park, MD, Se H. Park, MD, Jung Han Kim, MD, Jung Mi Kwon, MD, Sung Yong Oh, MD, Hyun Jung Kim, MD, Hyorak Lee, MD, Kihyun Kim, MD, Jin Seok Ahn, MD, Won Seog Kim, MD, Keunchil Park, MD

Blood (2005) 106 (11): 1769.

https://doi.org/10.1182/blood.V106.11.1769.1769

Published: 2005

Journal Articles

Predictive Value of Cytogenetics on Outcomes of Stem Cell Transplantation in Acute Myeloid Leukemia.

Jinny Park, M.D., Ph.D., Mark H. Lee, M.D., Ph.D., Se-Hoon Lee, M.D., Joon Oh Park, M.D., Ph.D., Kihyun Kim, M.D., Chul W. Jung, M.D., Ph.D., Won Seok Kim, M.D., Ph.D., Young Suk Park, M.D., Ph.D., Young-Hyuck Im, M.D., Ph.D., Won Ki Kang, M.D., Ph.D., Keunchil Park, M.D., Ph.D.

Blood (2004) 104 (11): 4397.

https://doi.org/10.1182/blood.V104.11.4397.4397

Published: 2004

Journal Articles

CHOP Followed by Radiotherapy for Localized Aggressive Primary Gastric Lymphoma: Results of a Multi Center Phase II Study.

Yeon Hee Park, M.D., Won Seog Kim, M.D., Baek-Yeol Ryoo, M.D., Sung Hyun Yang, M.D., Mi Sook Kim, M.D., Seung-Sook Lee, M.D., Kihyun Kim, M.D., Keon Woo Park, M.D., Chul W. Jung, M.D., Yong Chan Ahn, M.D., Do Hoon Lim, M.D., Young H. Ko, M.D., Keunchil Park, M.D.

Blood (2004) 104 (11): 3306.

https://doi.org/10.1182/blood.V104.11.3306.3306

Published: 2004

Journal Articles

A Randomized Trial of Short-Course Preemptive Ganciclovir Compared with Conventional Ganciclovir Therapy To Prevent Cytomegalovirus Infection after Allogeneic Stem Cell Transplantation.

Keun W. Park, MD, Jeeyun Lee, MD, Jinny Park, MD, Young Kim Ho, Mark H. Lee, MD, Se-Hoon Lee, MD, Jung H. Kang, MD, Kihyun Kim, MD, Chul W. Jung, MD, Won S. Kim, MD, Joon O. Park, MD, Young H. Im, MD, Young S. Park, MD, Won K. Kang, MD, Keunchil Park, MD

Blood (2004) 104 (11): 3162.

https://doi.org/10.1182/blood.V104.11.3162.3162

Published: 2004

Journal Articles

Direct Intramarrow Injection of CD34+ Cells May Improve Long-Term Engraftment in Nonhuman Primates.

Chul W. Jung, MD, Julia C. Morris, Brian Beard, PhD, Tobias Neff, MD, PhD, Kate Beebe, Hans-Peter Kiem, MD, PhD

Blood (2004) 104 (11): 2103.

https://doi.org/10.1182/blood.V104.11.2103.2103

Published: 2004

Journal Articles

T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28

C Renner, S Ohnesorge, G Held, S Bauer, W Jung, JP Pfitzenmeier, M Pfreundschuh

Blood (1996) 88 (1): 236–241.

https://doi.org/10.1182/blood.V88.1.236.236

Published: 1996

NARROW

Tuspetinib Myeloid Kinase Inhibitor Safety and Efficacy As Monotherapy and Combined with Venetoclax in Phase 1/2 Trial of Patients with Relapsed or Refractory (R/R) Acute Myeloid Leukemia (AML)

A Phase 1/2 Dose Escalation Study of the Myeloid Kinase Inhibitor HM43239 in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Multicenter Phase II Study to Evaluate Therapeutic Efficacy of Imatinib Mesylate in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease

Long-Term Update from the Open-Label Extension of the NEURO-TTR Study in Patients with Hereditary Transthyretin Amyloidosis

Final Study Results of Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 48 Months Follow-up

Intravenous Iron Supplementation Alone for Treatment of Anemia in Cancer Patients

Deeper Molecular Response in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 36 Months Follow-up

Overall Survival by Prognosis Score in High-Risk Myelodysplastic Syndromes (MDS) Patients Receiving Decitabine Treatment: Results From Clinical Experience

Bone Marrow Cellularity Is a Single Most Important Independent Prognostic Factor In AML Patients with t(8;21)

Clinical Characteristics of Thrombotic Thrombocytopenic Purpura with Severe ADAMTS13 Deficiency

Molecular Predictive Markers in Dose Escalation Treatment for Suboptimal Responders to Standard Dose Imatinib in CML

Prediction of Survival in Patients with Myelodysplastic Syndrome According to WHO Classification-Based Prognostic Scoring System (WPSS).

Clinical Features and Treatment Outcomes of Primary Testicular Lymphoma.

Prospective Clinical Study of Surgical Resection Followed by CHOP in Localized Intestinal Lymphoma.

A Randomized Trial of Heparin Plus Anti-Thrombin III (ATIII) vs. Heparin Alone To Prevent VOD after HSCT.

Predictive Value of Cytogenetics on Outcomes of Stem Cell Transplantation in Acute Myeloid Leukemia.

CHOP Followed by Radiotherapy for Localized Aggressive Primary Gastric Lymphoma: Results of a Multi Center Phase II Study.

A Randomized Trial of Short-Course Preemptive Ganciclovir Compared with Conventional Ganciclovir Therapy To Prevent Cytomegalovirus Infection after Allogeneic Stem Cell Transplantation.

Direct Intramarrow Injection of CD34+ Cells May Improve Long-Term Engraftment in Nonhuman Primates.

T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only